Biotech Values

[jb_118]

Re: MNTA Copaxone review timing.

Although I would remind us that Wheeler was very conservative in his last conference call in managing down expectations about FDA timing. He noted it is going much slower than mEnox, and while it is moving forward, they wish it were going faster. My completely subjective WAG was guiding towards the end of the year or even into next year rather than 1H 2011.